Role of the endocannabinoid system in diabetes and diabetic complications
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of the endocannabinoid system in diabetes and diabetic complications
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 173, Issue 7, Pages 1116-1127
Publisher
Wiley
Online
2015-06-16
DOI
10.1111/bph.13226
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy
- (2015) Zoltán V. Varga et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?
- (2015) Sabine Steffens et al. CURRENT DRUG TARGETS
- Unknown
- (2015) Enkui Hao et al. MOLECULAR MEDICINE
- Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity
- (2014) Mariëtte R. Boon et al. FASEB JOURNAL
- Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice
- (2014) Federica Barutta et al. KIDNEY INTERNATIONAL
- Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy
- (2014) Tony Jourdan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Painful diabetic neuropathy
- (2014) A. Peltier et al. BMJ-British Medical Journal
- The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: Transporters
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Vascular targets for cannabinoids: animal and human studies
- (2013) Christopher Stanley et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders
- (2013) Cristoforo Silvestri et al. Cell Metabolism
- Cannabinoid Receptor 2 Expression in Human Proximal Tubule Cells is Regulated by Albumin Independent of ERK1/2 Signaling
- (2013) Kayte A. Jenkin et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Modulating the endocannabinoid system in human health and disease - successes and failures
- (2013) Pál Pacher et al. FEBS Journal
- Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasingde novosynthesis of long-chain ceramides
- (2013) Resat Cinar et al. HEPATOLOGY
- CB1Cannabinoid Receptors Couple to Focal Adhesion Kinase to Control Insulin Release
- (2013) Katarzyna Malenczyk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes
- (2013) Monika Buraczynska et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome
- (2013) Svetlana Slavic et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
- (2013) Tony Jourdan et al. NATURE MEDICINE
- The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
- (2013) Adam J. Pawson et al. NUCLEIC ACIDS RESEARCH
- Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models
- (2013) Fabrizio Vincenzi et al. PAIN
- Mechanisms of Diabetic Complications
- (2013) Josephine M. Forbes et al. PHYSIOLOGICAL REVIEWS
- Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies
- (2012) Sabine Steffens et al. BRITISH JOURNAL OF PHARMACOLOGY
- Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
- (2012) Joseph Tam et al. Cell Metabolism
- Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy
- (2012) M. Rajesh et al. DIABETES
- Ibipinabant attenuates β-cell loss in male Zucker diabetic fatty rats independently of its effects on body weight
- (2012) K. Rohrbach et al. DIABETES OBESITY & METABOLISM
- Blockade of Cannabinoid Receptor 1 Improves Insulin Resistance, Lipid Metabolism, and Diabetic Nephropathy in db/db Mice
- (2012) D. H. Nam et al. ENDOCRINOLOGY
- “De-liver-ance” From CB1: A Way to Counteract Insulin Resistance?
- (2012) Vincenzo Di Marzo GASTROENTEROLOGY
- Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in Mice
- (2012) Jie Liu et al. GASTROENTEROLOGY
- Endocannabinoids and the renal proximal tubule: An emerging role in diabetic nephropathy
- (2012) Kayte A. Jenkin et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Endocannabinoids regulate adipokine production and the immune balance of omental adipose tissue in human obesity
- (2012) Q Ge et al. INTERNATIONAL JOURNAL OF OBESITY
- Effect of the Cannabinoid Receptor-1 antagonist SR141716A on human adipocyte inflammatory profile and differentiation
- (2012) Ravi Murumalla et al. Journal of Inflammation-London
- Overexpression of Cannabinoid CB2 Receptor in the Brain Induces Hyperglycaemia and a Lean Phenotype in Adult Mice
- (2012) S. Y. Romero-Zerbo et al. JOURNAL OF NEUROENDOCRINOLOGY
- Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes
- (2012) Gema Vera et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Cannabinoids Induce Pancreatic -Cell Death by Directly Inhibiting Insulin Receptor Activation
- (2012) W. Kim et al. Science Signaling
- The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications
- (2011) Béla Horváth et al. AMERICAN JOURNAL OF PATHOLOGY
- The case for peripheral CB1receptor blockade in the treatment of visceral obesity and its cardiometabolic complications
- (2011) George Kunos et al. BRITISH JOURNAL OF PHARMACOLOGY
- Central Endocannabinoid Signaling Regulates Hepatic Glucose Production and Systemic Lipolysis
- (2011) J. D. O'Hare et al. DIABETES
- Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy
- (2011) F. Barutta et al. DIABETES
- Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line
- (2011) A. B. El-Remessy et al. DIABETOLOGIA
- Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity
- (2011) A. Quercioli et al. EUROPEAN HEART JOURNAL
- Is lipid signaling through cannabinoid 2 receptors part of a protective system?
- (2011) P. Pacher et al. PROGRESS IN LIPID RESEARCH
- Peripheral effects of the endocannabinoid system in energy homeostasis: Adipose tissue, liver and skeletal muscle
- (2011) Cristoforo Silvestri et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Rimonabant-mediated changes in intestinal lipid metabolism and improved renal vascular dysfunction in the JCR:LA-cp rat model of prediabetic metabolic syndrome
- (2010) James C. Russell et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function
- (2010) Vedat Tiyerili et al. BASIC RESEARCH IN CARDIOLOGY
- Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells
- (2010) Mohanraj Rajesh et al. BRITISH JOURNAL OF PHARMACOLOGY
- CB1cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model
- (2010) Partha Mukhopadhyay et al. BRITISH JOURNAL OF PHARMACOLOGY
- CB1 Cannabinoid Receptors and their Associated Proteins
- (2010) Allyn Howlett et al. CURRENT MEDICINAL CHEMISTRY
- Targeting the MCP-1/CCR2 System in Diabetic Kidney Disease
- (2010) Sara Giunti et al. Current Vascular Pharmacology
- Cannabinoid Receptor Stimulation Impairs Mitochondrial Biogenesis in Mouse White Adipose Tissue, Muscle, and Liver: The Role of eNOS, p38 MAPK, and AMPK Pathways
- (2010) L. Tedesco et al. DIABETES
- Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
- (2010) F. Barutta et al. DIABETES
- Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age
- (2010) J. Agudo et al. DIABETOLOGIA
- Effect of rimonabant, the cannabinoid CB1 receptor antagonist, on peripheral nerve in streptozotocin-induced diabetic rat
- (2010) Wei Jing Liu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Rimonabant, a cannabinoid CB1 receptor antagonist, attenuates mechanical allodynia and counteracts oxidative stress and nerve growth factor deficit in diabetic mice
- (2010) Francesca Comelli et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
- (2010) Joseph Tam et al. JOURNAL OF CLINICAL INVESTIGATION
- CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes
- (2009) Partha Mukhopadhyay et al. CARDIOVASCULAR RESEARCH
- Effect of the Monocyte Chemoattractant Protein-1/CC Chemokine Receptor 2 System on Nephrin Expression in Streptozotocin-Treated Mice and Human Cultured Podocytes
- (2009) E. Tarabra et al. DIABETES
- Randomized Placebo-Controlled Double-Blind Clinical Trial of Cannabis-Based Medicinal Product (Sativex) in Painful Diabetic Neuropathy: Depression is a major confounding factor
- (2009) D. Selvarajah et al. DIABETES CARE
- Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy
- (2009) Partha Mukhopadhyay et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cannabinoid CB1 receptor activation stimulates neurite outgrowth and inhibits capsaicin-induced Ca2+ influx in an in vitro model of diabetic neuropathy
- (2009) Fan Zhang et al. NEUROPHARMACOLOGY
- Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
- (2009) Vanessa Deveaux et al. PLoS One
- CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways
- (2008) Fabrizio Montecucco et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search